GRCE

Grace Therapeutics, Inc. - Common Stock (GRCE)

About Grace Therapeutics, Inc. - Common Stock (GRCE)

Grace Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002, and is headquartered in Princeton, NJ.

Details

Daily high

$2.38

Daily low

$2.28

Price at open

$2.30

52 Week High

$4.96

52 Week Low

$1.75

Market cap

31.4M

Dividend yield

0.00%

Volume

9,658

Avg. volume

24,279

P/E ratio

-1.85

Grace Therapeutics, Inc. - Common Stock News